OL-010 Sequential use of nitazoxanide (NTZ) as a salvage therapy in patient with recurrent mild to moderate Clostridium difficile infection (CDI): a prospective, open-label, randomized clinical trial

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 14; p. S5
Main Authors Basu, P.P, Shah, N.J, Krishnaswamy, N, Korapati, R, Tammisetti, S, Tang, C.C
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 2010
Subjects
Infectious Disease
Pulmonary/Respiratory
Online AccessGet full text

Cover

More Information
ISSN:1201-9712
1878-3511
DOI:10.1016/S1201-9712(10)60014-8